Cerity Partners
ORGO icon

Cerity Partners’s Organogenesis Holdings ORGO Stock Holding History

Cerity Partners’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Buy
127,579
+64,670
+103% +$158K ﹤0.01% 2769
2026
Q1 		$149K Sell
62,909
-3,670
-6% -$12.7K ﹤0.01% 2951
2025
Q4 		$345K Sell
66,579
-4,183
-6% -$20.3K ﹤0.01% 2322
2025
Q3 		$299K Buy
70,762
+381
+0.5% +$1.77K ﹤0.01% 2285
2025
Q2 		$258K Sell
70,381
-4,499
-6% -$16.8K ﹤0.01% 2231
2025
Q1 		$323K Buy
74,880
+24,362
+48% +$98.4K ﹤0.01% 1989
2024
Q4 		$161K Sell
50,518
-193
-0.4% -$648 ﹤0.01% 2275
2024
Q3 		$145K Buy
50,711
+20,757
+69% +$58.2K ﹤0.01% 2381
2024
Q2 		$83.9K Buy
+29,954
New +$80.4K ﹤0.01% 2131

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cerity Partners's ORGO Position: Q2 2026 in Review

Cerity Partners increased its Organogenesis Holdings (ORGO) stake by 103% in Q2 2026, buying an estimated $158K and bringing the position to 127,579 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

Cerity Partners first reported a position in ORGO in Q2 2024 and has held it in 9 quarters since. The position peaked at $345K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Cerity Partners held 127,579 shares of Organogenesis Holdings worth $310K as of Q2 2026.
  • Cerity Partners bought 64,670 Organogenesis Holdings shares in Q2 2026, an estimated $158K.
  • Organogenesis Holdings made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2769 holding.
  • Cerity Partners first reported a position in Organogenesis Holdings in Q2 2024 and has held it in 9 quarters since.
  • Cerity Partners's Organogenesis Holdings position peaked at $345K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.